Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tsubota LaboratoryTSE:4890 +0.34%60 Net Current Asset Value is 円32.03 as of Mar. 2026. GuruFocus rates TSE:4890 with a GF Score™ of 60/100 and a GF Value™ of 円95.50 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 565 Medical Devices & Instruments companies, Tsubota Laboratory ranks worse than 73.45% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Tsubota Laboratory's net current asset value per share for the quarter that ended in Mar. 2026 was 円32.03.
The historical rank and industry rank for Tsubota Laboratory's Net Current Asset Value or its related term are showing as below:
TSE:4890'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 6.61 Med: 8.09 Max: 11.36
Current: 11.03
During the past 7 years, the highest Price-to-Net-Current-Asset-Value Ratio of Tsubota Laboratory was 11.36. The lowest was 6.61. And the median was 8.09.
TSE:4890's Price-to-Net-Current-Asset-Value is ranked worse than 73.45% of 565
companies
in the Medical Devices & Instruments industry
Industry Median: 5.04
vs TSE:4890: 11.03
Tsubota Laboratory (TSE:4890) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Tsubota Laboratory Net Current Asset Value Related Terms
Tsubota Laboratory Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Tsubota Laboratory's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4890 vs ABT, SYK, MDT: Net Current Asset Value Comparison
For the Medical Devices subindustry, Tsubota Laboratory's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tsubota Laboratory Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tsubota Laboratory's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Tsubota Laboratory's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of 円32.03 mean?
Tsubota Laboratory (TSE:4890) has a Net Current Asset Value of 円32.03 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Tsubota Laboratory and its competitors. According to the industry distribution chart, Tsubota Laboratory ranks #415 out of 565 companies in the Medical Devices & Instruments industry, placing it in the top 73.5%.
Is Tsubota Laboratory's Net Current Asset Value too high?
Tsubota Laboratory's current Net Current Asset Value is 円32.03. Based on the distribution chart, Tsubota Laboratory ranks #415 out of 565 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Tsubota Laboratory has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tsubota Laboratory's Net Current Asset Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Tsubota Laboratory ranks #415 out of 565 companies for Net Current Asset Value. This places Tsubota Laboratory in the lower half of its industry. The industry median Net Current Asset Value is 5.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 5.04, based on 565 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Tsubota Laboratory and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 5.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tsubota Laboratory's current Net Current Asset Value is 円32.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tsubota Laboratory stock overvalued right now?
Based on GuruFocus' analysis, Tsubota Laboratory (TSE:4890) is currently considered Significantly Overvalued. The stock's GF Value™ is 円95.50, compared to a current price of 円299.00 — trading 213.1% above its estimated fair value. The current Net Current Asset Value is 円32.03. Tsubota Laboratory's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Tsubota Laboratory (TSE:4890), the current Net Current Asset Value is 円32.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tsubota Laboratory (TSE:4890) Overvalued in 2026?
Based on GuruFocus' analysis, Tsubota Laboratory stock appears to be overvalued.
The current stock price of 円299.00 is trading 213.1% above its estimated GF Value™ of 円95.50.
GuruFocus considers Tsubota Laboratory to be Significantly Overvalued.
Key valuation signals for TSE:4890:
Net Current Asset Value: 円32.03
GF Value™: 円95.50 vs. price of 円299.00 (213.1% above fair value)
No single metric tells the full story. See the TSE:4890 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tsubota Laboratory Inc is engaged in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.
60GF Score
Get the complete analysis for TSE:4890
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4890 has been successfully added to your 
